Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | V125F |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RET V125F lies within the extracellular domain of the Ret protein (UniProt.org). V125F has not been characterized in the scientific literature and therefore, its effect on Ret protein function is unknown (PubMed, Feb 2024). |
Associated Drug Resistance | |
Category Variants Paths |
RET mutant RET V125F |
Transcript | NM_020975.6 |
gDNA | chr10:g.43102377G>T |
cDNA | c.373G>T |
Protein | p.V125F |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_020975.6 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406779.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406744.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406763.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406771.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406784.1 | chr10:g.43111306G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406765.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406759.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406780.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406782.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406769.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406787.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406772.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406773.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406760.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406785.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_001406781.1 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
NM_020630 | chr10:g.43102377G>T | c.373G>T | p.V125F | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|